Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Time course of vascular response after an a priori strategy of bare metal stent implantation post-dilated with a paclitaxel-coated balloon: Implementation of a three-dimensional analysis algorithm with optical coherence tomography.

Otto S, Gassdorf J, Nitsche K, Gutiérrez-Chico JL, Kryvanos A, Goebel B, Figulla HR, Poerner TC.

Cardiol J. 2016;23(3):296-306. doi: 10.5603/CJ.a2016.0018. Epub 2016 Apr 11.

PMID:
27064798
3.

Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.

Poerner TC, Otto S, Gassdorf J, Nitsche K, Janiak F, Scheller B, Goebel B, Jung C, Figulla HR.

Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146. Epub 2014 Nov 4.

4.

Accuracy of self-report in assessing Fitzpatrick skin phototypes I through VI.

Eilers S, Bach DQ, Gaber R, Blatt H, Guevara Y, Nitsche K, Kundu RV, Robinson JK.

JAMA Dermatol. 2013 Nov;149(11):1289-94. doi: 10.1001/jamadermatol.2013.6101.

PMID:
24048361
5.

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L; Heart Failure Association of the European Society of Cardiology (HFA).

Eur J Heart Fail. 2013 Jul;15(7):808-17. doi: 10.1093/eurjhf/hft050. Epub 2013 Mar 28.

6.

Thoracic neoplasms at the Jena reference center for soft tissue tumors.

Nitsche K, Günther B, Katenkamp D, Petersen I.

J Cancer Res Clin Oncol. 2012 Mar;138(3):415-24. doi: 10.1007/s00432-011-1108-8. Epub 2011 Dec 9.

PMID:
22160181
7.

Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.

Nitsche K, Ehrmann DA.

Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):717-30. doi: 10.1016/j.beem.2010.08.001. Review.

8.

EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).

Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors A, Nielsen OW, Zannad F, Tavazzi L; Heart Failure Association of ESC (HFA).

Eur J Heart Fail. 2010 Oct;12(10):1076-84. doi: 10.1093/eurjhf/hfq154. Epub 2010 Aug 29.

9.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

10.

Early versus delayed, provisional eptifibatide in acute coronary syndromes.

Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators.

N Engl J Med. 2009 May 21;360(21):2176-90. doi: 10.1056/NEJMoa0901316. Epub 2009 Mar 30.

11.

Haemodynamic and clinical effects of ularitide in decompensated heart failure.

Mitrovic V, Seferovic PM, Simeunovic D, Ristic AD, Miric M, Moiseyev VS, Kobalava Z, Nitsche K, Forssmann WG, Lüss H, Meyer M.

Eur Heart J. 2006 Dec;27(23):2823-32. Epub 2006 Oct 30.

12.

Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial.

Mitrovic V, Lüss H, Nitsche K, Forssmann K, Maronde E, Fricke K, Forssmann WG, Meyer M.

Am Heart J. 2005 Dec;150(6):1239.

PMID:
16338265
13.

[Continuous molsidomine infusion in acute myocardial infarct. Comparison with nitroglycerin infusion].

Djonlagic H, Funke K, Lessmann J, Nitsche K, Kreymann G, Lipke M, Fuchs M.

Med Klin (Munich). 1994 Jul;89 Suppl 2:10-6. German. No abstract available.

PMID:
7968893
14.

Gas-phase quenching of excitations as a probe of dynamics in porous silicas.

Drake JM, Levitz P, Klafter J, Turro NJ, Nitsche KS, Cassidy KF.

Phys Rev Lett. 1988 Aug 15;61(7):865-868. No abstract available.

PMID:
10039450
15.

Influence of the growth retardant tetcyclacis on cell division and cell elongation in plants and cell cultures of sunflower, soybean, and maize.

Nitsche K, Grossmann K, Sauerbrey E, Jung J.

J Plant Physiol. 1985 Mar;118(3):209-18. doi: 10.1016/S0176-1617(85)80222-4. Epub 2012 Jan 2.

PMID:
23196005
16.

Increased incidence of side effects after encainide: a newly developed antiarrhythmic drug.

Berchtold-Kanz E, Schwarz G, Hust M, Nitsche K, Just H.

Clin Cardiol. 1984 Sep;7(9):493-7.

17.

Q-T prolongation and torsades de pointes in a patient with subarachnoid hemorrhage.

Hust MH, Nitsche K, Hohnloser S, Böhm B, Just H.

Clin Cardiol. 1984 Jan;7(1):44-8.

18.

[Torsades de pointes and ventricular flutter].

Hust MH, Hohnloser S, Nitsche K, Just H.

Internist (Berl). 1984 Jan;25(1):68-71. German. No abstract available.

PMID:
6370896
20.

[Value of the intervention test in assessing cardiac arrhythmias].

Nitsche K, Füller S, Hust MH, Wehrle H, Löllgen H, Just H.

Cardiology. 1983;70 Suppl 1:61-6. German. No abstract available.

PMID:
6850698
Items per page

Supplemental Content

Loading ...
Write to the Help Desk